Florida Cancer Specialists & Research Institute Selects the Zyno Medical ZynoFlo Infusion Pump for its Infusion Centers
ZynoFlo to Enhance the Infusion Workflow and Patient Safety
Natick, MA – September 30, 2016……… ZynoFlo to Enhance the Infusion Workflow and Patient Safety.
Zyno Medical, LLC, a global medical device manufacturer focused on IV infusion pumps, patient safety and providing clinical workflow improvements, announced that Florida Cancer Specialists & Research Institute (FCS) has selected the ZynoFlo Z-800WF infusion pump for all of its treatment locations.
Zyno Medical’s ZynoFlo wireless integrated cloud-based system is specifically designed to provide nursing workflow efficiencies, patient safety, and revenue-related benefits, and compliments the established reliability and durability of the Z-800 series infusion pump platform. The ZynoFlo wireless integrated system is the latest advancement in infusion technology for community-based oncology practices and hospital oncology infusion centers.
ZynoFlo bridges the gap between drug dispensing systems, infusion therapy processes, and EMR systems by creating a connected flow of in-patient-context information between these systems and oncology infusion workflow processes. One of the tools that assists in this effort is Zyno’s patented Patient Query feature, which provides easy electronic retrieval of in-patient-context medication orders by a nurse from the infusion pump, a process that is complemented by posting information to the EMR after an infusion is complete.
As a clinical and administrative tool, ZynoFlo optimizes nursing workflow productivity and patient throughput while enhancing patient safety and enabling nurses to spend more time with patients. In addition, the automatic capture and documentation of billing information provides productivity benefits and unprecedented confidence in revenue capture and billing accuracy. ZynoFlo also provides data analytical and reporting tools that enable the visibility, accountability and measurement that can serve as a foundation for clinical and operational continuous process improvement initiatives.
FCS COO Todd Schonherz said, “We are excited to implement the most current generation of infusion technology at Florida Cancer Specialists. It represents our continued commitment to invest in the best technology tools available to serve our patients. Our decision was based on a comprehensive RFP process followed by month-long trials with the leading vendors. The ZynoFlo system provided a compelling array of benefits for our patients and our clinical and operational processes that led to a clear decision for FCS. We look forward to our partnership with Zyno Medical to fully realize the benefits of this exciting technology.”
“We are very pleased to partner with FCS to bring the latest in infusion technology to their patients.” said Dr. Chaoyoung Lee, the president and CEO of Zyno Medical, LLC. “The ZynoFlo wireless integrated system is an excellent fit for FCS as a tool to help them reach their goals for enhanced patient safety, clinical workflow efficiency, and continuous clinical and operational process improvement, while also enabling nurses to maximize their time spent with patients.”